BASi
Purdue Research Park
2701 Kent Avenue
West Lafayette
Indiana
47906-1382
United States
Tel: 765-463-4527
Fax: 765-497-1102
Website: http://www.basinc.com/
59 articles about BASi
-
NanoViricides Files Quarterly Report for Period Ending March 31, 2018; Company Has Over A Year's Worth of Cash in Hand, and It Is Scaling Up Production of Certain Herpecide Program Drug Candidates
5/22/2018
NanoViricides, Inc. (NYSE MKT: NNVC) (the "Company") a global leader in the development of highly effective antiviral therapies based on a novel nanomedicines platform (the "Company"), filed its quarterly report for its third quarter of financial year 2018.
-
BASi Reports Second Quarter Results
5/15/2017
-
BASi Announces Appointment Of Scientific Advisor
5/1/2017
-
BASi Names Philip A. Downing Senior Vice President Of Preclinical Services
3/9/2017
-
BASi Reports First Quarter Results
2/14/2017
-
BASi Reports Fiscal 2016 Full Year And Fourth Quarter Results
12/22/2016
-
BASi Names Alan Loch Director Of Business Development
12/21/2016
-
BASi Launches Embrace Automation Grant Program With Culex NxT Automated Blood Sampling System
8/25/2016
-
BASi Reports Third Quarter Results
8/11/2016
-
BASi Expands Electrochemical Offerings By Partnering With PalmSens BV
7/27/2016
-
BASi Reports Second Quarter Results
5/12/2016
-
BASi Introduces The Next Generation Of Electrochemical Analyzer With The Release Of The Epsilon Eclipse
3/29/2016
-
BASi Reports First Quarter Results
2/16/2016
-
BASi Reports Fiscal 2015 Full Year And Fourth Quarter Results
12/17/2015
-
BASi Names Dawn M. Joseph Director Of Business Development
12/16/2015
-
BASi Names Dawn M. Joseph Director Of Business Development
12/15/2015
-
BASi Names Wendy Perrow To Board Of Directors
12/14/2015
-
BASi Announces Enhancements To The Company’s Laboratory Information Management System (LIMS)
7/15/2015
-
BASi Reports Second Quarter Results
5/14/2015
-
BASi Names Philip A. Downing Vice President Of Preclinical Services
3/17/2015